Wall Street ends higher as investors bet on positive earnings season



(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)

By Shreyashi Sanyal and Sinéad Carew

Oct 19 (Reuters) - U.S. stock indexes closed higher on Tuesday with the biggest boosts from the technology and healthcare sectors as investors appeared to bet on solid quarterly reports even as some worried that it was too early to celebrate.

In its fifth straight session of gains, the benchmark S&P 500 index .SPX finished just 0.4% below its early September record close while the Dow Jones Industrials average .DJI ended the day about 0.5% below its record reached in mid-August.

Johnson & Johnson's JNJ.N shares added 2.3% providing a big boost to the S&P 500 after it raised its 2021 adjusted profit forecast. Insurer Travelers Cos Inc TRV.N climbed 1.6% after beating its profit estimates.

High-profile technology and communications companies were also big S&P boosts with Apple Inc AAPL.O , Facebook FB.O and Microsoft MSFT.O all rising.

But in the second week of earnings with a "very small sample" of releases, Steve Sosnick, chief strategist at Interactive Brokers, worried about a possible pullback.

"We're seeing volatility measures like the VIX flipping from nervous to complacent in a really short period of time," said Sosnick. "We may be a bit ahead of ourselves. The mostly likely scenario is that we make one more run at new S&P highs and then we pull back, subject to earnings."

The CBOE market volatility index .VIX fell 0.6 points after earlier hitting 15.57, its lowest level since mid-August.

Analysts now expect S&P 500 earnings to rise 32.4% from a year earlier, according to Refinitiv data.

"The key for the market to going up from here will not be higher multiples, it will have to be higher earnings. That's why it's so important to pay attention to what those profit margins do going forward and what the trajectory of GDP looks like," said Eric Marshall, portfolio manager at Hodges Funds.

"Investors will be paying very close attention to pricing power, how companies are dealing with labor shortages and inflationary cost pressures within their business."

The Dow Jones Industrial Average .DJI rose 198.7 points, or 0.56%, to 35,457.31, the S&P 500 .SPX gained 33.17 points, or 0.74%, to 4,519.63 and the Nasdaq Composite .IXIC added 107.28 points, or 0.71%, to 15,129.09.

Ten of the eleven major S&P 500 sectors closed higher, with healthcare stocks .SPXHC , up 1.3% after dropping 0.7% in Monday's session. The next biggest gainer was utilities .SPLRCU , which rose 1.26% after falling almost 1% Monday.

Netflix Inc NFLX.O , after closing up 0.2%, added slightly to gains after the bell when quarterly results showed that global interest in Korean thriller "Squid Game" lured more new customers than expected.

Tesla Inc TSLA.O , which closed down 0.7%, is due to release results on Wednesday, with investors watching for indications of its performance in China.

Procter & Gamble Co PG.N , fell 1% during the session, after it warned that it would have to raise prices of some products to counter higher commodity and freight costs.

However, Walmart Inc WMT.N shares added 2% after being added to Goldman Sachs "Americas Conviction List."

Helping the healthcare sector on Tuesday was drugmaker Merck & Co Inc MRK.N , which rose 3% while Pfizer Inc PFE.N climbed 1.9% following the release of a competitor's COVID-19 drug study results.

Its competitor, Atea Pharmaceuticals Inc AVIR.O , fell 66% after the company's antiviral pill, being developed with Roche ROG.S , failed to help patients with mild and moderate COVID-19.

Advancing issues outnumbered declining ones on the NYSE by a 1.51-to-1 ratio; on Nasdaq, a 1.69-to-1 ratio favored advancers.

The S&P 500 posted 44 new 52-week highs and 1 new lows; the Nasdaq Composite recorded 72 new highs and 69 new lows.

On U.S. exchanges 9.5 billion shares changed hands compared with the 10.29 billion moving average for the last 20 sessions.
Reporting by Shreyashi Sanyal and Devik Jain in Bengaluru; Sinéad Carew in New York, Editing by Saumyadeb Chakrabarty, Shounak Dasgupta and Aurora Ellis

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Gumagamit kami ng cookies para mabigyan ka ng mahusay na karanasan sa aming website. Magbasa pa o palitan ang iyong cookie settings.

Babala sa Risk: Ang iyong kapital ay maaaring malugi. Ang mga produktong naka-leverage ay maaaring hindi para sa lahat. Tingnan ang aming Risk Disclosure.